Atlas FDA

HEALTHTRONICS LITHOTRON LIHTOTRIPSY SYSTEM

FDA premarket approval P970019/S003 · decided 1998-11-18

Approval details

PMA number
P970019
Supplement
S003
Supplement type
Normal 180 Day Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
HEALTHTRONICS LITHOTRON LIHTOTRIPSY SYSTEM
Generic name
Lithotriptor, extracorporeal shock-wave, urological
Applicant
Healthtronics Surgical Services, Inc.
Date received
1998-07-23
Decision date
1998-11-18
Days to decision
118 days
Decision code
APRL
Product code
LNS
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Marietta, GA
Statement
Approval for modifications to the LithoTron(TM) Lithotripsy System's labeling to reflect the results of this final report. Based upon the information submitted, FDA believes that the postapproval report demonstrates that hypertension is not a long-term risk of extracorporeal shock wave lithotripsy, and that this postapproval requirement is now considered complete.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
TWINTRODE ELC 134 ELECTRODE (K012785)Healthtronics Surgical Services, Inc.2001-11-16
HEALTHTRONIC OMEGA TRAC (K881902)Healthtronics Surgical Services, Inc.1988-06-22